BioWave Overview

  • Founded
  • 1997

Founded
  • Status
  • Private

  • Employees
  • 41

Employees
  • Latest Deal Type
  • Debt - PPP

  • Latest Deal Amount
  • $484K

  • Investors
  • 2

BioWave General Information

Description

Developer of neuromodulation therapy medical devices designed to provide pain relief. The company's devices can be used for the treatment of chronic, acute, and postoperative musculoskeletal pains, enabling patients to alleviate pain through effective neurostimulation services.

Contact Information

Website
www.biowave.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Primary Office
  • 8 Knight Street
  • Suite 201
  • Norwalk, CT 06851
  • United States
+1 (877) 000-0000

BioWave Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioWave Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Debt - PPP 01-May-2020 $484K 00.000 Completed Generating Revenue
5. Later Stage VC (Series E) 20-Mar-2020 00.000 00.000 Completed Generating Revenue
4. Later Stage VC (Series D) 29-Jan-2016 00000 00.000 000.00 Completed Generating Revenue
3. Later Stage VC 19-Sep-2007 00000 00.000 000.00 Completed Generating Revenue
2. Later Stage VC 27-Mar-2002 $821K $1.82M 00.000 Completed Generating Revenue
1. Early Stage VC (Series A) $1M $1M 000 Completed Startup
To view BioWave’s complete valuation and funding history, request access »

BioWave Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D 0,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series C 00,000,000 00.000000 00 00.0 00.0 00 00.0 00.000
Series B 3,028,075 $0.010000 $0.54 $0.54 1x $0.54 6.69%
Series A 1,971,925 $0.010000 $0.54 $0.54 1x $0.54 4.36%
To view BioWave’s complete cap table history, request access »

BioWave Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of neuromodulation therapy medical devices designed to provide pain relief. The company's devices can be used
Therapeutic Devices
Norwalk, CT
41 As of 2022
00.000
000000000 - 00.000

000000

tate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proide
00000000000 0000000
Austin, TX
00 As of 0000
000.00
0000 0000-00-00
00000000000 000.00

00000

quat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla p
00000000000 0000000
Redwood City, CA
000 As of 0000
00000
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

BioWave Competitors (6)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
MicroTransponder Venture Capital-Backed Austin, TX 00 000.00 00000000000 000.00
00000 Formerly VC-backed Redwood City, CA 000 00000 00000000000 00000
00000 0000 Venture Capital-Backed Shelton, CT 000 00000 00000000000 00000
00000000 0000000 Formerly VC-backed Dublin, Ireland 00 00000 000000000 00000
00000000 Venture Capital-Backed Mount Olive, NJ 00 00000 00000000000 00000
To view BioWave’s complete competitors history, request access »

BioWave Patents

BioWave Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200121925-A1 Electrotherapy and neurostimulation medical device apparatus and method Pending 23-Oct-2018 00000000000
US-20210178158-A1 Wearable system for an electrotherapy device Pending 23-Oct-2018 00000000000
US-20140303682-A1 Noninvasive or percutaneous nerve stimulation Granted 08-Apr-2013 00000000000 00
US-9220895-B2 Noninvasive or percutaneous nerve stimulation Active 08-Apr-2013 00000000000 0
CA-2945483-A1 Noninvasive or percutaneous nerve stimulation Abandoned 08-Apr-2013 A61N1/36021
To view BioWave’s complete patent history, request access »

BioWave Executive Team (6)

Name Title Board Seat Contact Info
Rob Wolter Chief Executive Officer
Bradford Siff Founder, President & Board Member
Lance Lundberg Co-Chairman
You’re viewing 3 of 6 executive team members. Get the full list »

BioWave Board Members (7)

Name Representing Role Since
Bradford Siff BioWave Founder, President & Board Member 000 0000
Bruce Lev Self Board Member 000 0000
Charles Meythaler BioWave Board Member 000 0000
Lance Lundberg BioWave Co-Chairman 000 0000
Robert Adler BioWave Co-Chairman 000 0000
You’re viewing 5 of 7 board members. Get the full list »

BioWave Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioWave Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Connecticut Innovations Venture Capital Minority 000 0000 000000 0
NorthStar Pain Management Venture Capital Minority 000 0000 000000 0
To view BioWave’s complete investors history, request access »